Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naleen Raj Bhandari

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Healthcare (Basel, Switzerland)|March 6, 2019
Impact of The Affordable Care Act's Elimination of Cost-Sharing on the Guideline-Concordant Utilization of Cancer Preventive Screenings in the United States Using Medical Expenditure Panel SurveyNaleen Raj Bhandari, Chenghui Li
Research in Social & Administrative Pharmacy : RSAP|January 26, 2018
Reliability and validity of SF-12v2 among adults with self-reported cancerNaleen Raj Bhandari, Niranjan Kathe, Corey Hayes, et al.
Urologic Oncology|August 24, 2018
Health-related quality of life among elderly Americans diagnosed with upper tract urothelial carcinomaMohamed Kamel, Naleen Raj Bhandari, Rodney Davis, et al.
Healthcare (Basel, Switzerland)|April 27, 2017
Reliability and Validity of the Medical Outcomes Study Short Form-12 Version 2 (SF-12v2) in Adults with Non-Cancer PainCorey J Hayes, Naleen Raj Bhandari, Niranjan Kathe, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 6, 2023
Biomarker Testing, Treatment, and Outcomes in Patients With Advanced/Metastatic Non-Small Cell Lung Cancer Using a Real-World DatabaseNaleen Raj Bhandari, Lisa M Hess, Dan He, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 23, 2018
Assessment of Reliability and Validity of SF-12v2 among a Diabetic PopulationNiranjan Kathe, Corey J Hayes, Naleen Raj Bhandari, et al.
BMC Cancer|April 26, 2023
Correction: Characteristics and outcomes of patients with RET-fusion positive non-small lung cancer in real-world practice in the United StatesLisa M Hess, Yimei Han, Yajun Emily Zhu, et al.
Journal of Medical Economics|February 9, 2024
Integrated budget impact model to estimate the impact of introducing selpercatinib as a tumor-agnostic treatment option for patients with <i>RET</i>-altered solid tumors in the USNaleen Raj Bhandari, Adrienne M Gilligan, Julie Myers, et al.
BMC Cancer|January 6, 2021
Characteristics and outcomes of patients with RET-fusion positive non-small lung cancer in real-world practice in the United StatesLisa M Hess, Yimei Han, Yajun Emily Zhu, et al.
Thyroid Research|February 13, 2022
Diagnostic characteristics, treatment patterns, and clinical outcomes for patients with advanced/metastatic medullary thyroid cancerRohan Parikh, Lisa M Hess, Elizabeth Esterberg, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Healthcare (Basel, Switzerland)|March 6, 2019
Impact of The Affordable Care Act's Elimination of Cost-Sharing on the Guideline-Concordant Utilization of Cancer Preventive Screenings in the United States Using Medical Expenditure Panel SurveyNaleen Raj Bhandari, Chenghui Li
Research in Social & Administrative Pharmacy : RSAP|January 26, 2018
Reliability and validity of SF-12v2 among adults with self-reported cancerNaleen Raj Bhandari, Niranjan Kathe, Corey Hayes, et al.
Urologic Oncology|August 24, 2018
Health-related quality of life among elderly Americans diagnosed with upper tract urothelial carcinomaMohamed Kamel, Naleen Raj Bhandari, Rodney Davis, et al.
Healthcare (Basel, Switzerland)|April 27, 2017
Reliability and Validity of the Medical Outcomes Study Short Form-12 Version 2 (SF-12v2) in Adults with Non-Cancer PainCorey J Hayes, Naleen Raj Bhandari, Niranjan Kathe, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 6, 2023
Biomarker Testing, Treatment, and Outcomes in Patients With Advanced/Metastatic Non-Small Cell Lung Cancer Using a Real-World DatabaseNaleen Raj Bhandari, Lisa M Hess, Dan He, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 23, 2018
Assessment of Reliability and Validity of SF-12v2 among a Diabetic PopulationNiranjan Kathe, Corey J Hayes, Naleen Raj Bhandari, et al.
BMC Cancer|April 26, 2023
Correction: Characteristics and outcomes of patients with RET-fusion positive non-small lung cancer in real-world practice in the United StatesLisa M Hess, Yimei Han, Yajun Emily Zhu, et al.
Journal of Medical Economics|February 9, 2024
Integrated budget impact model to estimate the impact of introducing selpercatinib as a tumor-agnostic treatment option for patients with <i>RET</i>-altered solid tumors in the USNaleen Raj Bhandari, Adrienne M Gilligan, Julie Myers, et al.
BMC Cancer|January 6, 2021
Characteristics and outcomes of patients with RET-fusion positive non-small lung cancer in real-world practice in the United StatesLisa M Hess, Yimei Han, Yajun Emily Zhu, et al.
Thyroid Research|February 13, 2022
Diagnostic characteristics, treatment patterns, and clinical outcomes for patients with advanced/metastatic medullary thyroid cancerRohan Parikh, Lisa M Hess, Elizabeth Esterberg, et al.
Pageof 5